logo

Coherus Oncology Inc

Coherus CFO's Quiet RSU‑Triggered Sale Raises "Is the Board Capitalizing on a Short‑Term Upswing?"

Coherus CFO’s Quiet RSU‑Triggered Sale Raises “Is the Board Capitalizing on a Short‑Term Upswing?”

Coherus insider sales show routine tax‑planning, not a price collapse: CFO’s 1,715‑share sell at $1.55 and CEO’s 11,839 shares highlight short‑term liquidity moves, but fundamentals remain solid and the company stays a low‑beta, value‑oriented biote…
3 minutes to read